Achilles Therapeutics Plc buy BiotechBee
Start price
17.03.24
/
60%
€0.98
Target price
31.12.25
€2.50
Performance (%)
-7.18%
End price
14.12.24
€0.91
Summary
This prediction ended on 14.12.24 with a price of €0.91. With a performance of -7.18%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Achilles Therapeutics Plc | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to BiotechBee what are the pros and cons of Achilles Therapeutics Plc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Achilles Therapeutics Plc diskutieren
In the thread Trading Achilles Therapeutics Plc
Stopped prediction by BiotechBee for Achilles Therapeutics Plc
Achilles Therapeutics Plc
Start price
Target price
Perf. (%)
€0.97
18.02.24
18.02.24
€2.00
31.01.26
31.01.26
0.52%
17.03.24
17.03.24
Could be very worthwhile Investment >20% year
